Abstract
B CLL is a monoclonal proliferation of lymphocytes which express the CD5 antigen (CD5+ CLL). Rare exceptions (less than 10%) are CD5-, as are the majority of B PLL. We have studied the clinical, cytological and immunophenotypic characteristics of a series of 12 CD5-CLL and have established a score which allows the distinction between CD5+ CLL, CD5- CLL and PLL. Among the CD5- CLL, there were significantly more cases with advanced stage (Rai and Binet) and splenomegaly. The cytological study found more mixed CLL according to FAB classification (more prolymphocytes). There were significantly more CD23-, FMC7+, SIg strong positive cases. A score from 0 to 6 was established based on clinical, cytological and immunophenotypic criteria. Typical CD5+ CLL was scored 0, score 6 corresponded to typical PLL. There were significantly more higher scores amongst CD5- CLL. It therefore appears that CD5- CLLs share certain features with B PLL. The use of this scoring system will allow determination of prognosis within these different categories, thus identifying groups which require specific therapy.
References
May 4, 1992·Annals of the New York Academy of Sciences·G B FaguetP Bertin
Nov 15, 1992·Cancer·A Batata, B Shen
May 1, 1992·British Journal of Haematology·A S KurecF R Davey
Sep 13, 1990·The New England Journal of Medicine·G JuliussonG Gahrton
May 1, 1989·American Journal of Hematology·A OrfaoA Lopez Borrasca
Jun 1, 1989·Journal of Clinical Pathology·J M BennettC Sultan
Feb 1, 1989·Annals of Internal Medicine
May 1, 1974·British Journal of Haematology·D A GaltonG J Goldenberg
Aug 1, 1983·Cancer Genetics and Cytogenetics·S Pittman, D Catovsky
Feb 2, 1984·The New England Journal of Medicine·T HanA A Sandberg
Feb 1, 1982·The Journal of Experimental Medicine·F Caligaris-CappioG Janossy
Jul 1, 1981·Cancer·J L BinetF Gremy
Jan 1, 1994·Leukemia & Lymphoma·E Matutes, D Catovsky
Jan 1, 1991·Leukemia & Lymphoma·E LegacH Merle-Beral
Citations
Nov 1, 1996·Leukemia Research·F Salomon-NguyenG Flandrin
Nov 22, 2002·Leukemia Research·Chen WangBernard Fernandes
Mar 1, 1997·Cancer Genetics and Cytogenetics·J DierlammD K Hossfeld
Feb 12, 1999·Cancer Genetics and Cytogenetics·C M DascalescuD Leroux
Oct 9, 2009·Leukemia & Lymphoma·Sumeet GujralChandralekha Nair
Feb 1, 1997·Leukemia & Lymphoma·K MaloumG Dighiero
Aug 28, 1998·Leukemia & Lymphoma·G CartronP Colombat
Jan 12, 2008·American Journal of Hematology·Maria GoldanigaLuca Baldini
Feb 13, 2003·British Journal of Haematology·Georges JungPhilippe Hénon
Nov 26, 2002·American Journal of Hematology·Salwa S SheikhAdam Bagg
Oct 3, 1999·Pathology International·N NakamuraM Abe
Aug 31, 2002·Hematological Oncology·Gerassimos A PangalisMaria K Angelopoulou
Jan 17, 2003·Leukemia·L CroL Baldini
Aug 1, 2020·The Cochrane Database of Systematic Reviews·Nina KreuzbergerNicole Skoetz
May 6, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Cengiz DemirSenar Ebinç